Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

More from Invega Sustenna

Other strengths and forms by Unimed Unihealth Pharmaceuticals Ltd.

Indications & Uses

Invega Sustenna is indicated for:

Pharmacology

Paliperidone palmitate is hydrolyzed to paliperidone, which is the major active metabolite of risperidone. How paliperidone works is not clear. Its effect in schizophrenia could come from a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism.

In vitro, paliperidone acts as an antagonist at the central D2 and 5HT2A receptors. The binding affinities (Ki values) are 1.6-2.8 nM for D2 and 0.8-1.2 nM for 5HT2A receptors. Paliperidone is also active as an antagonist at the α1 and α2 adrenergic receptors and at H1 histaminergic receptors, and this may explain some of the other effects of the drug. It has no affinity for cholinergic muscarinic receptors or for β1 and β2-adrenergic receptors. In vitro, the pharmacological activity of the (+)- and (-)- paliperidone enantiomers is qualitatively and quantitatively similar.

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

For schizophrenia, paliperidone palmitate initiation dosing is 234 mg on Day 1 and 156 mg on Day 8. The monthly maintenance dose is 39 to 234 mg, and the maximum monthly dose is 234 mg.

For schizoaffective disorder, the initiation dosing is the same, 234 mg on Day 1 and 156 mg on Day 8. The monthly maintenance dose is 78 to 234 mg, and the maximum monthly dose is 234 mg.

The maintenance dose is administered 5 weeks after the first injection. For schizophrenia, the recommended maintenance dose is 117 mg. Some patients may do better on a lower or higher maintenance dose, chosen from the other available strengths (39 mg, 78 mg, 156 mg and 234 mg). The dose is adjusted based on tolerability and/or efficacy, using these strengths. The 39 mg strength was not studied in the long-term schizoaffective disorder study.

Side Effects

The most common side effects of Paliperidone Palmitate were injection site reactions, somnolence/sedation, dizziness, akathisia and extrapyramidal disorder. These were reactions that occurred in at least 5% of people and at least twice as often as with placebo.

Cautions & Contraindications

Warnings & Precautions

Paliperidone Palmitate raises the incidence of cerebrovascular adverse reactions (for example stroke and transient ischemic attack), including stroke, in elderly patients with dementia-related psychosis. For neuroleptic malignant syndrome, stop the drug immediately and monitor the patient closely. With QT prolongation, avoid using Paliperidone Palmitate with other drugs that increase the QT interval, and avoid it in patients who have risk factors for a prolonged QT interval. If tardive dyskinesia develops, discontinue the drug if that is clinically appropriate. Metabolic changes need monitoring, meaning hyperglycemia/diabetes mellitus, dyslipidemia and weight gain. For orthostatic hypotension and syncope, monitor heart rate and blood pressure. Warn patients with known cardiovascular or cerebrovascular disease, and those at risk of dehydration or syncope. Leukopenia, neutropenia and agranulocytosis are a concern too. Perform complete blood counts (CBC) in patients with a pre-existing low white blood cell count (WBC) or a history of leukopenia or neutropenia. Consider discontinuing Paliperidone Palmitate if there is a clinically significant decline in WBC and no other cause is found. Hyperprolactinemia: prolactin elevations occur and persist during chronic administration. There is a potential for cognitive and motor impairment, so use caution when operating machinery. For seizures, use the medicine cautiously in patients with a history of seizures or with conditions that lower the seizure threshold.

Contraindications

Don't use Paliperidone Palmitate if you are known to be hypersensitive to paliperidone, to risperidone, or to any of the excipients in the medicine.

Pregnancy & Breastfeeding

There isn't much published data on paliperidone in human breast milk, but the few reports that exist do show it is present there. Nothing is known about how it affects a breastfed infant, and nothing is known about its effect on milk production.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Use in Special Populations

Safety and effectiveness of Paliperidone Palmitate have not been established in patients under 18 years of age. It is not recommended in patients with moderate or severe renal impairment. Paliperidone Palmitate has not been studied in patients with hepatic impairment. Based on a study with oral paliperidone, no dose adjustment is required in patients with mild or moderate hepatic impairment.

Storage

Keep Paliperidone Palmitate at room temperature. Short spells between 15°C and 30°C are permitted. Don't mix it with any other product or diluent.

Drug Interactions

Open checker →
Major Rifampicin
Moderate Paliperidone

Common questions about Invega Sustenna 100 mg

What is Invega Sustenna 100 mg IM Injection?

Invega Sustenna 100 mg IM Injection is a medicine that contains Paliperidone Palmitate. It is made by Unimed Unihealth Pharmaceuticals Ltd. It belongs to the Atypical neuroleptic drugs group of medicines.

What is Invega Sustenna used for?

Invega Sustenna is used for: Schizophrenia.

What are the side effects of Invega Sustenna?

The most common side effects of Paliperidone Palmitate were injection site reactions, somnolence/sedation, dizziness, akathisia and extrapyramidal disorder. These were reactions that occurred in at least 5% of people and at least twice as often as with placebo.

Can I take Invega Sustenna during pregnancy or while breastfeeding?

There isn't much published data on paliperidone in human breast milk, but the few reports that exist do show it is present there. Nothing is known about how it affects a breastfed infant, and nothing is known about its effect on milk production. Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

How should I store Invega Sustenna?

Keep Paliperidone Palmitate at room temperature. Short spells between 15°C and 30°C are permitted.

Can I take other medicines with Invega Sustenna?

Some medicines can interact with Paliperidone Palmitate, for example: Carbamazepine, Rifampicin, Paliperidone. Tell your doctor or pharmacist about every medicine you take.

Do I need a prescription for Invega Sustenna?

Invega Sustenna is a prescription (Rx) medicine. Take it as your doctor advises.

Last updated: 18 Aug 2026